Low‐dose UVA1 phototherapy for proximal and acral scleroderma in systemic sclerosis

RF Rose, D Turner, MJD Goodfield… - Photodermatology …, 2009 - Wiley Online Library
Previous studies report the benefit of UVA1 phototherapy in treating acrosclerosis in patients
with systemic sclerosis. We carried out a retrospective study to examine the effectiveness of …

Ultraviolet A1 phototherapy for treatment of acrosclerosis in systemic sclerosis: controlled study with half‐side comparison analysis

F Durand, D Staumont, A Bonnevalle… - Photodermatology …, 2007 - Wiley Online Library
Background: Treatments currently used in acrosclerosis for patients with systemic sclerosis
(SS) are not very efficient and are associated with adverse effects. Several reports concern …

Low-dose UVA1 phototherapy in systemic sclerosis: effects on acrosclerosis

A Kreuter, F Breuckmann, A Uhle, N Brockmeyer… - Journal of the American …, 2004 - Elsevier
BACKGROUND: Increased collagen synthesis, vascular damage, and T-lymphocytic
infiltration contribute to the development of systemic sclerosis. Preliminary studies revealed …

Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis

A Morita, K Kobayashi, I Isomura, T Tsuji… - Journal of the American …, 2000 - Elsevier
Background: The presence of an inflammatory infiltrate consisting of helper T cells and a
dysregulated matrix metabolism leading to excessive deposition of collagen are two …

[PDF][PDF] Successful treatment of microstomia with UVA1 phototherapy in systemic sclerosis

A Tewari, T Garibaldinos, J Lai‐Cheong… - Photodermatology …, 2011 - Citeseer
To the Editor, The introduction of phototherapy has substantially changed the therapeutic
response of localized scleroderma (LS). Systemic agents have been proposed for the …

Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study

C Andres, A Kollmar, M Mempel, R Hein… - British Journal of …, 2010 - academic.oup.com
Summary Background Ultraviolet (UV) A1 phototherapy is an effective anti‐inflammatory
treatment modality that influences fibroblast functions. Objectives To document the effects of …

Ultraviolet A1 phototherapy for the treatment of localized scleroderma

T Furuhashi, K Torii, K Ikumi, H Kato… - The Journal of …, 2020 - Wiley Online Library
Ultraviolet (UV) A1 phototherapy is effective for T‐cell‐mediated skin diseases such as
atopic dermatitis and mast cell‐mediated skin diseases such as mastocytoma. UVA1 …

Low-dose UVA1 phototherapy for treatment of localized scleroderma

M Kerscher, M Volkenandt, C Gruss, T Reuther… - Journal of the American …, 1998 - Elsevier
Background: For treatment of localized scleroderma numerous treatments, including ones
with potentially hazardous side effects, are currently used with only limited success …

Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review

EBM Kroft, NJG Berkhof, PCM van de Kerkhof… - Journal of the American …, 2008 - Elsevier
BACKGROUND: Ultraviolet (UV) A-1 phototherapy is now available for a variety of skin
diseases. Increasingly since 1995, there have been investigations of the efficacy of UVA-1 …

Effectiveness of medium‐dose ultraviolet A1 phototherapy in localized scleroderma

O Su, N Onsun, HK Onay, Y Erdemoglu… - International journal …, 2011 - Wiley Online Library
Abstract Background Recently, ultraviolet (UV) A1 phototherapy has been suggested as an
effective treatment for localized scleroderma (LS); however, the optimal dose of UVA1 still …